Inside Tx
Latest round
- Seed
Last raised
- May 2024
Total raised
- $1.4M
Investors
- 1
About Inside Tx
Inside Therapeutics was founded in 2022 in Paris, France, focusing on the advancement of nanoparticle and RNA-LNP formulations. The company was created by founders Audrey Nsamela and Robin Oliveres, with Thomas Guerinier serving as CEO.Inside Therapeutics specializes in the manufacturing of nanoparticles and RNA lipid nanoparticle (RNA-LNP) formulations. Their flagship product, the TAMARA system, enables rapid formulation of complex biopharmaceuticals in under ten seconds through a straightforward three-step process. This system is designed to assist pharmaceutical and biotechnology companies in drug development, facilitating transitions from discovery to in vivo testing while maintaining material efficiency and quality. Clients include organizations such as OSE Immunotherapeutics, which utilize Inside Therapeutics' technology to improve their RNA-LNP synthesis processes.Inside Therapeutics operates on a direct B2B transaction model, providing the TAMARA system along with tailored training packages to meet specific research and development needs. The revenue structure comprises initial sales of the TAMARA system and recurring income generated from training and support services aimed at optimizing the use of their technology in drug development. Additionally, the company is looking to broaden its reach into new markets, specifically targeting expansions into Asia and North America by late 2024.
Who invested in Inside Tx
1 investor across 1 round
See all investors in Inside Tx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 29, 2024
Amount
$1.4M
Investors
Questions about Inside Tx
Who invested in Inside Tx?
Inside Tx has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inside Tx raised?
Inside Tx has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Inside Tx last raise money?
Inside Tx's most recent round on record is a Seed, in May 2024.
What does Inside Tx do?
Inside Therapeutics was founded in 2022 in Paris, France, focusing on the advancement of nanoparticle and RNA-LNP formulations.
Where is Inside Tx headquartered?
Inside Tx is headquartered in Paris, France.
Which VCs invest in companies like Inside Tx?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back pharmaceuticals companies at Inside Tx's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Inside Tx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.